Israel Englander Vanda Pharmaceuticals Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Millennium Management LLC holds 16,237 shares of VNDA stock, worth $75,177. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,237

Previous 432,802 96.25%

Holding current value

$75,177

Previous $1.78 Million 94.88%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.91 - $6.5 $1.63 Million - $2.71 Million	-416,565 Reduced 96.25%	16,237 $91,000
Q1 2024 May 15, 2024	SELL	$3.47 - $4.61 $1.96 Million - $2.61 Million	-565,490 Reduced 56.65%	432,802 $1.78 Million
Q4 2023 Feb 14, 2024	BUY	$3.38 - $4.58 $1.41 Million - $1.92 Million	418,518 Added 72.19%	998,292 $4.21 Million
Q2 2023 Aug 14, 2023	SELL	$5.9 - $6.95 $6.97 Million - $8.21 Million	-1,181,954 Reduced 67.09%	579,774 $3.82 Million
Q1 2023 May 15, 2023	SELL	$6.18 - $7.99 $136,065 - $175,915	-22,017 Reduced 1.23%	1,761,728 $12 Million
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $11.2 Million - $17.9 Million	1,633,788 Added 1089.5%	1,783,745 $13.2 Million
Q3 2022 Nov 14, 2022	SELL	$9.44 - $11.76 $9.82 Million - $12.2 Million	-1,040,453 Reduced 87.4%	149,957 $1.48 Million
Q2 2022 Aug 15, 2022	BUY	$9.31 - $11.84 $3.32 Million - $4.22 Million	356,418 Added 42.74%	1,190,410 $13 Million
Q1 2022 May 16, 2022	BUY	$10.84 - $16.55 $4.27 Million - $6.53 Million	394,318 Added 89.68%	833,992 $9.43 Million
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $2.62 Million - $3.53 Million	-167,070 Reduced 27.54%	439,674 $6.9 Million
Q3 2021 Nov 15, 2021	BUY	$15.35 - $21.27 $5.39 Million - $7.47 Million	351,137 Added 137.37%	606,744 $10.4 Million
Q2 2021 Aug 16, 2021	SELL	$15.71 - $21.51 $7.24 Million - $9.92 Million	-461,108 Reduced 64.34%	255,607 $5.5 Million
Q1 2021 May 17, 2021	BUY	$13.42 - $20.28 $979,727 - $1.48 Million	73,005 Added 11.34%	716,715 $10.8 Million
Q4 2020 Feb 16, 2021	BUY	$9.77 - $13.81 $4.65 Million - $6.57 Million	476,053 Added 283.94%	643,710 $8.46 Million
Q3 2020 Nov 16, 2020	BUY	$9.32 - $12.02 $1.56 Million - $2.02 Million	167,657 New	167,657 $1.62 Million
Q2 2020 Aug 14, 2020	SELL	$9.66 - $12.02 $2.71 Million - $3.37 Million	-280,178 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$7.5 - $16.8 $2 Million - $4.48 Million	266,565 Added 1958.16%	280,178 $2.9 Million
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $5.55 Million - $7.83 Million	-448,362 Reduced 97.05%	13,613 $223,000
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $740,494 - $952,926	-60,350 Reduced 11.55%	461,975 $6.14 Million
Q2 2019 Aug 14, 2019	SELL	$13.37 - $18.85 $1.81 Million - $2.56 Million	-135,697 Reduced 20.62%	522,325 $7.36 Million
Q1 2019 May 14, 2019	BUY	$17.59 - $31.05 $1.27 Million - $2.24 Million	72,158 Added 12.32%	658,022 $12.1 Million
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $5.56 Million - $9.23 Million	293,273 Added 100.23%	585,864 $15.3 Million
Q3 2018 Nov 14, 2018	SELL	$18.25 - $23.0 $1.79 Million - $2.25 Million	-97,811 Reduced 25.05%	292,591 $6.72 Million
Q2 2018 Aug 14, 2018	SELL	$13.95 - $19.15 $8.45 Million - $11.6 Million	-605,873 Reduced 60.81%	390,402 $7.44 Million
Q1 2018 May 15, 2018	SELL	$14.05 - $20.2 $1.84 Million - $2.65 Million	-131,290 Reduced 11.64%	996,275 $16.8 Million
Q4 2017 Feb 14, 2018	SELL	$12.85 - $18.1 $4.02 Million - $5.67 Million	-313,196 Reduced 21.74%	1,127,565 $17.1 Million
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $22.2 Million - $27.2 Million	1,440,761	1,440,761 $25.8 Million

Others Institutions Holding VNDA

# of Institutions

156

Shares Held

45.1M

Call Options Held

136K

Put Options Held

220K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $262M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account